Repression of retrovirus-mediated transgene expression by interferons: implications for gene therapy
- PMID: 9371574
- PMCID: PMC230218
- DOI: 10.1128/JVI.71.12.9163-9169.1997
Repression of retrovirus-mediated transgene expression by interferons: implications for gene therapy
Abstract
Retrovirus-mediated gene transfer is commonly used in gene therapy protocols and has the potential to provide long-term expression of the transgene. Although expression of a retrovirus-delivered transgene is satisfactory in cultured cells, it has been difficult to achieve consistent and high-level expression in vivo. In this investigation, we explored the possibility of modulating transgene expression by host-derived cytokines. Normal human keratinocytes and dermal fibroblasts were transduced with recombinant retroviruses expressing a reporter gene (lacZ). Treatment of transduced cells with a proinflammatory cytokine, gamma interferon (IFN-gamma), significantly reduced lacZ expression to less than 25% of that of nontreated cells. The inhibition was concentration dependent (peak at 5 ng/ml) and time dependent (maximal at 16 h for transcript and 24 h for protein); expression remained repressed in the continued presence of IFN-gamma but returned to normal levels 24 h after IFN-gamma withdrawal. The decrease in beta-galactosidase activity appeared to result from decrease in steady-state lacZ mRNA levels. Inhibitors of transcription and translation blocked IFN-gamma-induced repression, suggesting involvement of newly synthesized protein intermediates. Similar results were obtained by treatment of transduced cells with IFN-alpha but not with other proinflammatory cytokines, including tumor necrosis factor alpha, interleukin-2 (IL-1), IL-4, and granulocyte colony-stimulating factor. Although the level of lacZ mRNA was reduced by >70% following IFN treatment, the rate of lacZ transcription was not significantly different from that for nontreated cells. These results suggest that IFN-mediated regulation of transgene expression is at a posttranscriptional level. Interestingly, IFN-gamma also suppressed transgene expression driven by a cellular promoter (involucrin) inserted in an internal position in the retroviral vector. The presence of the overlapping 3' untranslated regions in transcripts initiated from the internal promoter and the long terminal repeat is suggestive of a posttranscriptional regulation, likely at the level of RNA stabilization. These results provide direct evidence for modulatory effects of IFNs on retrovirus-mediated transgene expression and suggest that gene therapy results may be altered by host inflammatory responses.
Similar articles
-
Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression.Hum Gene Ther. 1997 Nov 20;8(17):2019-29. doi: 10.1089/hum.1997.8.17-2019. Hum Gene Ther. 1997. PMID: 9414251
-
Enhancing and suppressing effects of dexamethasone on transgene expression in vitro.Int J Mol Med. 2002 Jul;10(1):107-12. Int J Mol Med. 2002. PMID: 12060860
-
Retroviral gene transfer induced constitutive expression of interleukin-2 or interferon-gamma in irradiated human melanoma cells.Blood. 1992 Dec 1;80(11):2817-25. Blood. 1992. PMID: 1450408
-
Effects of interferon-gamma and tumor necrosis factor alpha on the expression of the genes encoding aggrecan, biglycan, and decorin core proteins in cultured human chondrocytes.Arthritis Rheum. 1998 Feb;41(2):274-83. doi: 10.1002/1529-0131(199802)41:2<274::AID-ART11>3.0.CO;2-Z. Arthritis Rheum. 1998. PMID: 9485085 Review.
-
Pharmacokinetic considerations regarding non-viral cancer gene therapy.Cancer Sci. 2008 May;99(5):856-62. doi: 10.1111/j.1349-7006.2008.00774.x. Epub 2008 Feb 19. Cancer Sci. 2008. PMID: 18294288 Free PMC article. Review.
Cited by
-
High-efficiency gene transfer into normal and adenosine deaminase-deficient T lymphocytes is mediated by transduction on recombinant fibronectin fragments.J Virol. 1998 Jun;72(6):4882-92. doi: 10.1128/JVI.72.6.4882-4892.1998. J Virol. 1998. PMID: 9573255 Free PMC article.
-
Trichostatin A up-regulates human papillomavirus type 11 upstream regulatory region-E6 promoter activity in undifferentiated primary human keratinocytes.J Virol. 1999 Jun;73(6):5026-33. doi: 10.1128/JVI.73.6.5026-5033.1999. J Virol. 1999. PMID: 10233965 Free PMC article.
-
Restricted cytokine production from mouse peritoneal macrophages in culture in spite of extensive uptake of plasmid DNA.Immunology. 2004 Mar;111(3):282-90. doi: 10.1111/j.1365-2567.2004.01814.x. Immunology. 2004. PMID: 15009428 Free PMC article.
-
Antiangiogenic gene therapy of cancer: recent developments.J Transl Med. 2004 Jun 25;2(1):22. doi: 10.1186/1479-5876-2-22. J Transl Med. 2004. PMID: 15219236 Free PMC article.
-
Prolonged gene expression in mouse lung endothelial cells following transfection with Epstein-Barr virus-based episomal plasmid.Gene Ther. 2003 May;10(9):822-6. doi: 10.1038/sj.gt.3301958. Gene Ther. 2003. PMID: 12704423 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical